These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34640490)

  • 21. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P; Porebska A; Bajer-Czajkowska A; Zywica A; Koziarska D; Podbielski J
    Ann Acad Med Stetin; 2007; 53(2):14-9. PubMed ID: 18557372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
    Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
    Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation.
    Polymeris AA; Meinel TR; Oehler H; Hölscher K; Zietz A; Scheitz JF; Nolte CH; Stretz C; Yaghi S; Stoll S; Wang R; Häusler KG; Hellwig S; Klammer MG; Litmeier S; Leon Guerrero CR; Moeini-Naghani I; Michel P; Strambo D; Salerno A; Bianco G; Cereda C; Uphaus T; Gröschel K; Katan M; Wegener S; Peters N; Engelter ST; Lyrer PA; Bonati LH; Grunder L; Ringleb PA; Fischer U; Kallmünzer B; Purrucker JC; Seiffge DJ
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):588-598. PubMed ID: 35396339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice.
    Osseby GV; Benatru I; Sochurkova D; Urbinelli R; Megherbi SE; Couvreur G; Moreau T; Wolf J; Giroud M
    Prev Med; 2004 Feb; 38(2):121-8. PubMed ID: 14715203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
    Law MR; Morris JK; Wald NJ
    BMJ; 2009 May; 338():b1665. PubMed ID: 19454737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
    Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
    G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.
    Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
    Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
    Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
    Antithrombotic Trialists' Collaboration
    BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis.
    Turner GM; Calvert M; Feltham MG; Ryan R; Fitzmaurice D; Cheng KK; Marshall T
    PLoS Med; 2016 Nov; 13(11):e1002169. PubMed ID: 27846215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001342. PubMed ID: 16855967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012169. PubMed ID: 28968483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China.
    Zhang J; Yang XA; Zhang Y; Wei JY; Yang F; Gao H; Jiao WW; Sun XL; Gao Q; Jiang W
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):125-131. PubMed ID: 27645612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy for the secondary prevention of stroke.
    Toyoda K
    Drugs; 2009; 69(6):633-47. PubMed ID: 19405547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
    Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic treatment after stroke due to intracerebral haemorrhage.
    Cochrane A; Chen C; Stephen J; Rønning OM; Anderson CS; Hankey GJ; Al-Shahi Salman R
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012144. PubMed ID: 36700520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.